U Of M Performs Clinical Trial On Treatment For COVID-19 Patients Experiencing ‘Cytokine Storm’

From CBS Minnesota:

August 13, 2020

MINNEAPOLIS (WCCO) — The University of Minnesota says they are undergoing a clinical trial for a possible new way to fight COVID-19.

The university reported they are using mesenchymal stem cells on a patient with COVID-19 and lung failure, the first treatment of its kind in the U.S. The clinical trial has been approved by the FDA.

Researchers say that this treatment hopes to halt the intense inflammatory response of the body as it fights the virus, best known as a “cytokine storm.” This immune response has been shown to cause extensive organ damage in some patients.

Read more at CBS Minnesota